Glenview is reportedly planning an activist stance, pushing for operational changes at
CVS Health Corporation. Meanwhile,
CVS has garnered investor attention, with its stock increasing by 4.36% on Sep 27. However, the US Federal Trade Commission has filed a lawsuit against
CVS Health and other Pharmacy Benefit Managers for allegedly inflating insulin prices. Furthermore, Bragar Eagel & Squire, P.C. is currently investigating
CVS. On the positive side, the
CVS Health Corporation has announced a quarterly dividend and is implementing support measures for the approaching Hurricane Helene. Despite these initiatives, the company’s financial trajectory has experienced some turbulence; the
CVS Health Corporation cut its 2024 forecast a third time, influenced by health insurance struggles. Concurrently, a class action lawsuit has been initiated against
CVS Health.
CVS has announced operational improvements, including the release of Well Market™ and the opening of two new Workforce Innovation Talent Centers, yet the company's 2024 guidance is revised down, causing the shares to fall by 18%. Following these events, CVS investors have been encouraged to join a fraud investigation against the
CVS Health Corporation.
Cvs Health Corporation CVS News Analytics from Tue, 05 Dec 2023 08:00:00 GMT to Mon, 30 Sep 2024 00:09:54 GMT -
Rating -3
- Innovation -5
- Information 6
- Rumor -5
